1. Putative role of pharmacogenetics to elucidate the mechanism of tardive dyskinesia in schizophrenia

   Loonen, A. J., Wilffert, B. & Ivanova, S. A., 5-Nov-2019, In : Pharmacogenomics.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine: A Pragmatic Randomized Controlled Trial (CYSCE Trial)

   van der Schans, J., Hak, E., Postma, M., Breuning, L., Brouwers, J. R. B. J., Ditters, K., Jansen, P. A. F., Kok, R. M., Maring, J. G., van Marum, R., Mulder, H., Nanninga, J., Oude Voshaar, R. C., Risselada, A. J., Vleugel, L., Stek, M., van Schaik, R. H. N., Berm, E. J. J. & Wilffert, B., 7-Nov-2019, In : Journal of Clinical Psychopharmacology. 39, 6, p. 583-590 8 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines

   Lunenburg, C. A. T. C., van der Wouden, C. H., Nijenhuis, M., Crommentuijn-van Rhenen, M. H., de Boer-Veger, N. J., Buunk, A. M., Houwink, E. J. F., Mulder, H., Rongen, G. A., van Schaik, R. H. N., van der Weide, J., Wilffert, B., Deneer, V. H. M., Swen, J. J. & Guchelaar, H-J., 19-Nov-2019, In : EJHG.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Remarkable outcomes in children and adolescents routinely treated for tuberculosis in the Netherlands, and factors associated with mortality and treatment default

   Gafar, F., Boveneind-Vrubleuskaya, van 't, N., Akkerman, O., Wilffert, B. & Alffenaar, J-W., Nov-2019, In : International Journal of Tuberculosis and Lung Disease. 22, 11, p. S143 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

5. The effects of amoxicillin on acute COPD exacerbations in the outpatient setting: A retrospective cohort study based on real‐world data

   Wang, Y., Bos, J., Schuiling-Veninga, C., Wilffert, B. & Hak, E., 2019, In : Pharmcoepidemiology and Drug Safety. 28, 52, 1208.

   Research output: Contribution to journal › Meeting Abstract › Academic

View all (353) »

1. Meest Innovatieve geneesmiddelen. Medicatie voor borstkanker, spierziekte en reuma ‘bekroond’

   Berend Wilffert

   22/12/2017

   1 Media contribution

   Press/Media: Expert Comment › Popular

View all (1) »

1. Implementation of Pharmacogenetics in Clinical Practice.

   Berend Wilffert (Invited speaker)

   23-Aug-2018 → 24-Aug-2018

   Activity: Talk or presentation › Professional

2. Implementation of Pharmacogenetics in Clinical Practice.

   Berend Wilffert (Invited speaker)

   23-Aug-2018 → 25-Aug-2018

   Activity: Talk or presentation › Professional

3. Implementation of Pharmacogenetics in Pharmacotherapy of Chronic Diseases.

   Berend Wilffert (Invited speaker)

   10-Aug-2018 → 11-Aug-2018

   Activity: Talk or presentation › Professional

View all (8) »

1. Poster Prize

   Bob Wilffert (Recipient), 2015

   Prize › Academic

2. Naunyn-Schmiedeberg-Preis für Pharmakologie

   Bob Wilffert (Recipient), 2011

   Prize › Academic

View all (2) »